- Home
- EPM vs CHRS Comparison
EPM vs CHRS Comparison
Compare EPM & CHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPM
- CHRS
- Stock Information
- Founded
- EPM 2003
- CHRS 2010
- Country
- EPM United States
- CHRS United States
- Employees
- EPM N/A
- CHRS N/A
- Industry
- EPM Oil & Gas Production
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EPM Energy
- CHRS Health Care
- Exchange
- EPM Nasdaq
- CHRS Nasdaq
- Market Cap
- EPM 188.8M
- CHRS 185.5M
- IPO Year
- EPM 1996
- CHRS 2014
- Fundamental
- Price
- EPM $4.94
- CHRS $1.52
- Analyst Decision
- EPM Strong Buy
- CHRS Strong Buy
- Analyst Count
- EPM 1
- CHRS 4
- Target Price
- EPM $8.25
- CHRS $5.38
- AVG Volume (30 Days)
- EPM 212.5K
- CHRS 10.1M
- Earning Date
- EPM 02-04-2025
- CHRS 11-06-2024
- Dividend Yield
- EPM 9.84%
- CHRS N/A
- EPS Growth
- EPM N/A
- CHRS N/A
- EPS
- EPM 0.14
- CHRS N/A
- Revenue
- EPM $87,172,000.00
- CHRS $304,340,000.00
- Revenue This Year
- EPM $13.15
- CHRS $1.64
- Revenue Next Year
- EPM N/A
- CHRS $16.98
- P/E Ratio
- EPM $34.89
- CHRS N/A
- Revenue Growth
- EPM N/A
- CHRS 44.19
- 52 Week Low
- EPM $4.59
- CHRS $0.66
- 52 Week High
- EPM $6.29
- CHRS $3.70
- Technical
- Relative Strength Index (RSI)
- EPM 26.48
- CHRS 52.47
- Support Level
- EPM $4.87
- CHRS $1.45
- Resistance Level
- EPM $5.29
- CHRS $1.85
- Average True Range (ATR)
- EPM 0.17
- CHRS 0.23
- MACD
- EPM -0.10
- CHRS -0.03
- Stochastic Oscillator
- EPM 5.94
- CHRS 3.88
About EPM Evolution Petroleum Corporation Inc.
Evolution Petroleum Corp is an independent oil and gas company operating in the United States. It is engaged predominantly in the acquisition, exploitation, and development of properties for the production of crude oil and natural gas, onshore in the United States. The company's revenues are generated from its crude oil, natural gas, and NGL production from the Jonah Field in Sublette County, Wyoming; the Williston Basin in North Dakota; the Barnett Shale located in North Texas; the Hamilton Dome Field in Wyoming; and the Delhi Field in Northeast Louisiana.
About CHRS Coherus BioSciences Inc.
Coherus BioSciences Inc is a commercial-stage biopharmaceutical company building an immuno-oncology franchise funded with cash generated by its diversified portfolio of FDA-approved therapeutics. The company is focused on the research, development, and commercialization of its portfolio of FDA-approved oncology products, including LOQTORZI. The company markets UDENYCA, a biosimilar of Neulasta in the United States, and expects to launch the FDA-approved Humira biosimilar YUSIMRY in the United States in 2023. The company generates revenue from the United States.